Pasithea Therapeutics Corp (NASDAQ: KTTA) started the day on Wednesday, with a price decrease of -10.19% at $0.97, before settling in for the price of $1.08 at the close. Taking a more long-term approach, KTTA posted a 52-week range of $0.28-$3.85.
The Healthcare sector firm’s twelve-monthly sales growth has been -282.28% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -282.28%. This publicly-traded company’s shares outstanding now amounts to $23.09 million, simultaneously with a float of $20.81 million. The organization now has a market capitalization sitting at $22.40 million. At the time of writing, stock’s 50-day Moving Average stood at $0.9379, while the 200-day Moving Average is $0.9147.
Pasithea Therapeutics Corp (KTTA) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Pasithea Therapeutics Corp’s current insider ownership accounts for 9.88%, in contrast to 12.41% institutional ownership. According to the most recent insider trade that took place on Nov 28 ’25, this organization’s Director bought 133,333 shares at the rate of 0.75, making the entire transaction reach 100,000 in total value, affecting insider ownership by 199,691. Preceding that transaction, on Nov 28 ’25, Company’s Chief Executive Officer bought 33,333 for 0.75, making the whole transaction’s value amount to 25,000. This particular insider is now the holder of 73,334 in total.
Pasithea Therapeutics Corp (NASDAQ: KTTA) Trading Performance Indicators
Let’s observe the current performance indicators for Pasithea Therapeutics Corp (KTTA). It’s Quick Ratio in the last reported quarter now stands at 4.02.
In the same vein, KTTA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -5.08, a figure that is expected to reach -0.18 in the next quarter.
Technical Analysis of Pasithea Therapeutics Corp (KTTA)
If we take a close look at the recent performances of Pasithea Therapeutics Corp (NASDAQ: KTTA), its last 5-days Average volume was 0.51 million that shows progress from its year to date volume of 0.43 million. During the previous 9 days, stock’s Stochastic %D was recorded 9.39% While, its Average True Range was 35.41.
Raw Stochastic average of Pasithea Therapeutics Corp (KTTA) in the period of the previous 100 days is set at 38.73%, which indicates a major rise in contrast to 12.19% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0867 that was higher than 0.0848 volatility it exhibited in the past 100-days period.
